These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Invasive fungal infections following liver transplantation: incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007). Raghuram A; Restrepo A; Safadjou S; Cooley J; Orloff M; Hardy D; Butler S; Koval CE Liver Transpl; 2012 Sep; 18(9):1100-9. PubMed ID: 22577087 [TBL] [Abstract][Full Text] [Related]
31. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial. Lin R; Xu X; Li Y; Sun J; Fan Z; Jiang Q; Huang F; Zhou H; Nie D; Guo Z; Mao Y; Xiao Y; Liu Q Transpl Infect Dis; 2014 Apr; 16(2):286-94. PubMed ID: 24593273 [TBL] [Abstract][Full Text] [Related]
32. Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole. Hayes D; Ball AM; Mansour HM; Martin CA; Flynn JD Exp Clin Transplant; 2011 Dec; 9(6):399-404. PubMed ID: 22142048 [TBL] [Abstract][Full Text] [Related]
33. Invasive fungal disease in patients treated for newly diagnosed acute leukemia. Hammond SP; Marty FM; Bryar JM; DeAngelo DJ; Baden LR Am J Hematol; 2010 Sep; 85(9):695-9. PubMed ID: 20652970 [TBL] [Abstract][Full Text] [Related]
34. Era effect on post-transplant survival adjusted for baseline risk factors in pediatric heart transplant recipients. Singh TP; Edwards LB; Kirk R; Boucek MM J Heart Lung Transplant; 2009 Dec; 28(12):1285-91. PubMed ID: 19782597 [TBL] [Abstract][Full Text] [Related]
35. Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Girmenia C; Raiola AM; Piciocchi A; Algarotti A; Stanzani M; Cudillo L; Pecoraro C; Guidi S; Iori AP; Montante B; Chiusolo P; Lanino E; Carella AM; Zucchetti E; Bruno B; Irrera G; Patriarca F; Baronciani D; Musso M; Prete A; Risitano AM; Russo D; Mordini N; Pastore D; Vacca A; Onida F; Falcioni S; Pisapia G; Milone G; Vallisa D; Olivieri A; Bonini A; Castagnola E; Sica S; Majolino I; Bosi A; Busca A; Arcese W; Bandini G; Bacigalupo A; Rambaldi A; Locasciulli A Biol Blood Marrow Transplant; 2014 Jun; 20(6):872-80. PubMed ID: 24631738 [TBL] [Abstract][Full Text] [Related]
36. Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections. Héquet D; Kralidis G; Carrel T; Cusini A; Garzoni C; Hullin R; Meylan PR; Mohacsi P; Mueller NJ; Ruschitzka F; Tozzi P; van Delden C; Weisser M; Wilhelm MJ; Pascual M; Manuel O; BMC Infect Dis; 2016 Jul; 16():321. PubMed ID: 27391967 [TBL] [Abstract][Full Text] [Related]
37. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547 [TBL] [Abstract][Full Text] [Related]
38. Incidence, Risk Factors and Outcomes of Delayed-onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients. Santos CA; Brennan DC; Yusen RD; Olsen MA Transplantation; 2015 Aug; 99(8):1658-66. PubMed ID: 25675196 [TBL] [Abstract][Full Text] [Related]